Heron Therapeutics is trading at $0.52 (+5.17%) in after-hours trading, moving higher despite a lack of company-specific catalysts.
- The price action appears driven by thin after-hours liquidity and a broader risk-on sentiment across major U.S. indexes and futures.
- No earnings reports, FDA updates, or major corporate announcements were identified for the July 30, 2026 session.
- Small-cap biotech shares often experience sharp moves on modest volume when overall market conditions are supportive.